Issue 4, 2003

Preparation and in vitro evaluation of a novel amphiphilic GdPCTA-[12] derivative; a micellar MRI contrast agent

Abstract

A novel amphiphilic GdPCTA-[12] derivative has been prepared. The complex formed micelles in aqueous solution with a relatively low CMC, 0.15 mM (25 °C). The concentration dependent T1-relaxivity (r1) of the system has been described. The maximum T1-relaxivity, 29.2 s−1 mM−1 (20 MHz, 25 °C), was higher than for previously described micellar MRI contrast agents. This high T1-relaxivity is a consequence of the favourable water residence time (τM) and the fact that the complex is heptadentate allowing two water molecules to coordinate to the gadolinium ion (q = 2).

Graphical abstract: Preparation and in vitro evaluation of a novel amphiphilic GdPCTA-[12] derivative; a micellar MRI contrast agent

Article information

Article type
Paper
Submitted
11 Nov 2002
Accepted
23 Dec 2002
First published
29 Jan 2003

Org. Biomol. Chem., 2003,1, 644-647

Preparation and in vitro evaluation of a novel amphiphilic GdPCTA-[12] derivative; a micellar MRI contrast agent

R. Hovland, C. Gløgård, A. J. Aasen and J. Klaveness, Org. Biomol. Chem., 2003, 1, 644 DOI: 10.1039/B211039C

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements